Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma
Clinical trial NCT07019181 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07019181
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2025-12-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.